CEO and co-founder of BoostSuite
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder and CEO, Lighter Capital
Chairman, CEO, & Founder, Alexandria Real Estate Equities
San Diego’s Biocom industry group is hosting this overview about the discovery, development, and regulatory processes for bringing a new drug to market. Participants will learn about the business and scientific decisions involved in moving a product forward from basic research into preclinical and clinical trials, as well as a detailed consideration of the regulatory requirements of clinical development. Post-approval commercial considerations and risk management will also be discussed. More information and online registration is here.